Lake Street Capital Raises Cellebrite DI (NASDAQ:CLBT) Price Target to $17.00
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective upped by Lake Street Capital from $13.50 to $17.00 in a research report released on Friday morning, Benzinga reports. Lake Street Capital currently has a buy rating on the stock. Several other research firms also recently weighed in on CLBT. JPMorgan Chase & Co. raised […]
More Stories
McKesson (NYSE:MCK) Issues FY 2025 Earnings Guidance
McKesson (NYSE:MCK – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share...
M. Kraus & Co Cuts Position in Thermo Fisher Scientific Inc. (NYSE:TMO)
M. Kraus & Co cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.2%...
Financial Survey: Gold Royalty (NYSE:GROY) & American International Ventures (OTCMKTS:AIVN)
Gold Royalty (NYSE:GROY – Get Free Report) and American International Ventures (OTCMKTS:AIVN – Get Free Report) are both small-cap basic...
iShares Bitcoin Trust (NASDAQ:IBIT) Shares Up 3.1% – What’s Next?
iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report)’s share price rose 3.1% during trading on Wednesday . The company traded...
Red Cat (NASDAQ:RCAT) Stock Price Up 17.1% – Still a Buy?
Red Cat Holdings, Inc. (NASDAQ:RCAT – Get Free Report) shares were up 17.1% on Wednesday . The company traded as...
Silvia Mccoll Wealth Management LLC Raises Stock Position in Vanguard Small-Cap Value ETF (NYSEARCA:VBR)
Silvia Mccoll Wealth Management LLC grew its stake in Vanguard Small-Cap Value ETF (NYSEARCA:VBR – Free Report) by 1.3% in...